Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.71)
# 732
Out of 5,148 analysts
477
Total ratings
41.3%
Success rate
10.36%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $35 → $37 | $17.70 | +109.04% | 9 | Mar 2, 2026 | |
| VCEL Vericel | Maintains: Buy | $60 → $64 | $34.42 | +85.94% | 19 | Feb 27, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $67 → $60 | $34.86 | +72.12% | 29 | Feb 25, 2026 | |
| ECOR electroCore | Maintains: Buy | $25 → $18 | $7.47 | +140.96% | 14 | Jan 26, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $102 → $130 | $88.54 | +46.83% | 5 | Jan 26, 2026 | |
| DCTH Delcath Systems | Reiterates: Buy | $30 | $9.08 | +230.40% | 16 | Jan 9, 2026 | |
| CGEN Compugen | Initiates: Buy | $4 | $2.22 | +80.18% | 1 | Jan 7, 2026 | |
| EKSO Ekso Bionics Holdings | Downgrades: Neutral | n/a | $10.01 | - | 17 | Dec 31, 2025 | |
| PYXS Pyxis Oncology | Maintains: Buy | $5 → $7 | $1.44 | +386.11% | 11 | Dec 19, 2025 | |
| ABSI Absci | Maintains: Buy | $7 → $8 | $2.68 | +198.51% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $13.22 | +240.39% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $17.44 | +106.42% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.70 | +440.54% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $156 → $54 | $6.55 | +724.43% | 8 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $155 | $101.29 | +53.03% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $106.90 | -12.07% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.5 → $9 | $3.56 | +152.81% | 14 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $32 | $15.40 | +107.79% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $8.71 | +49.25% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $47 | $53.99 | -12.95% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $3.27 | +52.91% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7,500 | $4.94 | +151,721.86% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.70 | +194.12% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.83 | +222.11% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.77 | +291.70% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.03 | +428.05% | 14 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.53 | +1,980.97% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $1.88 | +697.87% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.09 | +175.23% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.91 | +266.49% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.92 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.90 | +233.41% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.05 | -2.44% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.47 | +138.10% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $4.10 | +363.41% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $1.70 | +10,488.24% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $5.38 | +513.38% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $7.19 | +1,638.53% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.80 | +129.17% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.55 | +3,536.36% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.90 | +52.54% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.26 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.98 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.22 | +1,955.08% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.96 | +68.92% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.87 | +4,081.18% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.17 | +11,454.02% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.25 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $17.58 | -65.87% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.31 | +1,045.04% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $5.67 | +482.01% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $13.10 | -27.45% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $0.93 | +1,505,438.23% | 1 | Mar 5, 2020 |
Eton Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $35 → $37
Current: $17.70
Upside: +109.04%
Vericel
Feb 27, 2026
Maintains: Buy
Price Target: $60 → $64
Current: $34.42
Upside: +85.94%
Corcept Therapeutics
Feb 25, 2026
Maintains: Buy
Price Target: $67 → $60
Current: $34.86
Upside: +72.12%
electroCore
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $7.47
Upside: +140.96%
Mirum Pharmaceuticals
Jan 26, 2026
Maintains: Buy
Price Target: $102 → $130
Current: $88.54
Upside: +46.83%
Delcath Systems
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $9.08
Upside: +230.40%
Compugen
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.22
Upside: +80.18%
Ekso Bionics Holdings
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $10.01
Upside: -
Pyxis Oncology
Dec 19, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $1.44
Upside: +386.11%
Absci
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $2.68
Upside: +198.51%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $13.22
Upside: +240.39%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $17.44
Upside: +106.42%
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $3.70
Upside: +440.54%
Nov 18, 2025
Maintains: Buy
Price Target: $156 → $54
Current: $6.55
Upside: +724.43%
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $101.29
Upside: +53.03%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $106.90
Upside: -12.07%
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $3.56
Upside: +152.81%
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $15.40
Upside: +107.79%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $8.71
Upside: +49.25%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $53.99
Upside: -12.95%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $3.27
Upside: +52.91%
Nov 4, 2025
Assumes: Buy
Price Target: $7,500
Current: $4.94
Upside: +151,721.86%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.70
Upside: +194.12%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.83
Upside: +222.11%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.77
Upside: +291.70%
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $3.03
Upside: +428.05%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.53
Upside: +1,980.97%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $1.88
Upside: +697.87%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.09
Upside: +175.23%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.91
Upside: +266.49%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.92
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $0.90
Upside: +233.41%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.05
Upside: -2.44%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.47
Upside: +138.10%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $4.10
Upside: +363.41%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $1.70
Upside: +10,488.24%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $5.38
Upside: +513.38%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $7.19
Upside: +1,638.53%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $4.80
Upside: +129.17%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.55
Upside: +3,536.36%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.90
Upside: +52.54%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.26
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.98
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.22
Upside: +1,955.08%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.96
Upside: +68.92%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.87
Upside: +4,081.18%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.17
Upside: +11,454.02%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $18.25
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $17.58
Upside: -65.87%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.31
Upside: +1,045.04%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $5.67
Upside: +482.01%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $13.10
Upside: -27.45%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $0.93
Upside: +1,505,438.23%